title: Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.
authors.affiliation: Department of Internal Medicine, Newark Beth Israel Medical Center, Newark, NJ.. Electronic address: uyenphuong18@yahoo.com.
authors.forename: Phuong
authors.initials: P
authors.lastname: Vo
authors.forename: Elaine S
authors.initials: ES
authors.lastname: Jaffe
authors.forename: Lisa
authors.initials: L
authors.lastname: Cook
authors.forename: Catalina
authors.initials: C
authors.lastname: Ramos
authors.forename: Richard
authors.initials: R
authors.lastname: Childs
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001706:Biopsy; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D006086:Graft vs Host Disease; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D016219:Immunotherapy, Adoptive; D007372:Interferons / Q000008:administration & dosage; D008198:Lymph Nodes / Q000473:pathology; D020522:Lymphoma, Mantle-Cell / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D009364:Neoplasm Recurrence, Local; D011719:Pyrazines / Q000008:administration & dosage; D012074:Remission Induction; D019233:Retreatment; D000069283:Rituximab; D014184:Transplantation, Homologous
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001897:Boronic Acids; D011719:Pyrazines; D000069283:Rituximab; D000069286:Bortezomib; D007372:Interferons
keywords: Allogeneic hematopoietic stem cell transplantation; Bortezomib; Donor lymphocytes; Durable remission; Mantle cell lymphoma; PEG-interferon